NCT05741372View on ClinicalTrials.gov

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 7, 2023

Primary Completion Date

December 18, 2024

Study Completion Date

December 30, 2024

Conditions
Liver Cirrhosis
Interventions
DRUG

Rosuvastatin

Rosuvastatin

DRUG

Digoxin

Digoxin

DRUG

Metformin hydrochlorid

Metformin hydrochloride

DRUG

Furosemide

Furosemide

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05741372 - A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis | Biotech Hunter | Biotech Hunter